Fig. 3From: A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapya CLSM images of PC-3 cells treated with ATD-NPs or TD-NPs for 1 or 2 h. b, c Quantitatively analysis of cellular uptake of PC-3 cells (b) and LNCaP cells after treated with TD-NPs and ATD-NPs, respectively. Data showed mean ± SD, n = 3Back to article page